Remarkably, PIKFYVE inhibitors can selectively terminate autophagy-dependent cancer cells and pluripotent cancer stem cells that are PIKFYVE-dependent without having any such effect on normal cells [5,6,7,8,25,26,27,28]. This evidence concerns the gene PIKFYVE and cancer.